You are here: Industry Insights > licensing

News List

Verici DX Plc Reaches a Global Licensing and Commercialisation Agreement with Thermo Fisher Scientific B3C newswire
November 16, 2023
Verici Dx plc，today announced that it has signed an exclusive global licensing agreement with Thermo Fisher Scientific, to further develop an assay for pre-transplant prognostic testing for risk of early kidney rejection.
Altamira Therapeutics and Nuance Pharma Enter Into Exclusive Licensing and Distribution Agreement for Bentrio in China and Additional Asian Markets PharmaSources.com
March 08, 2022
Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics...
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics PharmaSources.com
March 08, 2022
Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, and Accure Therapeutics, a private translational neuroscience R&D company...
Everest Medicines, Singapore's EDDC Enter Global Licensing Agreement for COVID Oral Antivirals contractpharma
January 17, 2022
Everest gains exclusive global rights to a series of 3CL protease inhibitors to treat COVID-19.
Fareva, ApiJect Sign 10-Year Blow-Fill-Seal Licensing Agreement contractpharma
December 13, 2021
Invests $56.5M to fill-finish more than 500 million doses per year of vaccines and other large molecule injectable drugs using ApiJect's technology.
SPARC enters into licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target expresspharma
December 06, 2021
Under the agreement, Biomodifying is eligible for an upfront payment, milestone payments on pre-specified clinical, regulatory, and commercial milestones, as well as royalties on sales.
CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China prnasia
November 22, 2021
CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines...
Luoxin Pharmaceutical signs licensing agreement with Austria-based Marinomed Biotech AG for Budesolv® Budesonide Nasal Spray prnasia
October 22, 2021
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. (''Shandong Luoxin''), a subsidiary of Luoxin Pharmaceutical Group Stock Co., Ltd. ("Luoxin Pharmaceutical" or "the company") ...
QIAGEN and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements firstwordpharma
August 10, 2021
QIAGEN and OncXerna Therapeutics, Inc. today announced signing a master companion diagnostics (CDx) agreement to develop a NGS CDx for OncXerna's product candidate, Navicixizumab, and a non-exclusive license to the Xerna™ TME panel.
Norgine B.V. and US WorldMeds enter into exclusive licensing agreement to commercialise DFMO (eflornithine) in Europe, Commonwealth of Independent States, Australia and New Zealand prnasia
July 23, 2021
NORGINE B.V. today announced an exclusive licensing agreement by which Norgine will register and commercialise difluoromethylornithine, DFMO (eflornithine) in Europe, Commonwealth of Independent States, Australia and New Zealand.